[PERSON]
Tirzepatide
Featured in 9 tracked stories · first seen
Situations
Expanding therapeutic uses and regulatory concerns for GLP-1
43 clusters · 180 sources · last updated
Latest: Semaglutide study shows BMI reduction in children with obesity
Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow
GLP-1 drugs: clinical trends, safety, and market shifts
343 clusters · 1318 sources · last updated
Latest: FDA issues warning for GLP-1 drugs over vision loss risks
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt
Retatrutide development and regulatory actions
6 clusters · 32 sources · last updated
Latest: Anvisa recalls weight loss drug ingredients due to storage issues
Retatrutide, an investigational synthetic peptide developed by Eli Lilly, is being studied for its metabolic potential in managing food regulation, sugar, and weight. As a triple receptor agonist, it mimics natural gut a
Also covered in
-
Tirzepatide discontinuation linked to psychiatric symptoms in clinical report
[HEALTH] · 6 sources ·
-
Medical studies highlight new treatments for fatty liver and blood pressure
[HEALTH] · 2 sources ·